The SOS (Stenting Of Saphenous Vein Grafts) Trial
The SOS (Stenting Of Saphenous Vein Grafts) Randomized-controlled Trial of a Paclitaxel-eluting Stent vs. a Bare Metal Stent in Saphenous Vein Graft Lesions
Sponsor: Clark R. Gregg Fund, Harris Methodist Foundation
Listed as NCT00247208, this PHASE3 trial focuses on Arteriosclerosis and Coronary Artery Bypass and remains completed. Sponsored by Clark R. Gregg Fund, Harris Methodist Foundation, it has been updated 7 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Nov 2021 [monthly]
Completed PHASE3
-
Aug 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clark R. Gregg Fund, Harris Methodist Foundation
- Michael E. DeBakey VA Medical Center
- North Texas Veterans Healthcare System
- Onassis Cardiac Surgery Centre
- Southern Arizona VA Health Care System
- US Department of Veterans Affairs
- University of Arkansas
For direct contact, visit the study record on ClinicalTrials.gov .